To further analyze the potential of PAPSS1 and ESR1 as the predictive marker for therapy effectiveness in ovarian cancer, a receiver operating characteristic (ROC) analysis was performed to link gene expression to respond to therapy. The gene discussed is ESR1; the disease is ovarian carcinoma.